IBDEI1J3 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24433,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,24433,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,24434,0)
 ;;=E03.2^^107^1204^13
 ;;^UTILITY(U,$J,358.3,24434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24434,1,3,0)
 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
 ;;^UTILITY(U,$J,358.3,24434,1,4,0)
 ;;=4^E03.2
 ;;^UTILITY(U,$J,358.3,24434,2)
 ;;=^5002471
 ;;^UTILITY(U,$J,358.3,24435,0)
 ;;=E03.9^^107^1204^14
 ;;^UTILITY(U,$J,358.3,24435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24435,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,24435,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,24435,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,24436,0)
 ;;=E06.0^^107^1204^36
 ;;^UTILITY(U,$J,358.3,24436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24436,1,3,0)
 ;;=3^Thyroiditis,Acute
 ;;^UTILITY(U,$J,358.3,24436,1,4,0)
 ;;=4^E06.0
 ;;^UTILITY(U,$J,358.3,24436,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,24437,0)
 ;;=E06.1^^107^1204^37
 ;;^UTILITY(U,$J,358.3,24437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24437,1,3,0)
 ;;=3^Thyroiditis,Subacute
 ;;^UTILITY(U,$J,358.3,24437,1,4,0)
 ;;=4^E06.1
 ;;^UTILITY(U,$J,358.3,24437,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,24438,0)
 ;;=C73.^^107^1204^19
 ;;^UTILITY(U,$J,358.3,24438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24438,1,3,0)
 ;;=3^Malig Neop of Thyroid Gland
 ;;^UTILITY(U,$J,358.3,24438,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,24438,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,24439,0)
 ;;=E16.2^^107^1204^10
 ;;^UTILITY(U,$J,358.3,24439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24439,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,24439,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,24439,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,24440,0)
 ;;=E20.0^^107^1204^15
 ;;^UTILITY(U,$J,358.3,24440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24440,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,24440,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,24440,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,24441,0)
 ;;=E20.9^^107^1204^11
 ;;^UTILITY(U,$J,358.3,24441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24441,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,24441,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,24441,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,24442,0)
 ;;=E23.0^^107^1204^12
 ;;^UTILITY(U,$J,358.3,24442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24442,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,24442,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,24442,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,24443,0)
 ;;=E27.1^^107^1204^34
 ;;^UTILITY(U,$J,358.3,24443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24443,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,24443,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,24443,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,24444,0)
 ;;=E27.2^^107^1204^1
 ;;^UTILITY(U,$J,358.3,24444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24444,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,24444,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,24444,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,24445,0)
 ;;=E27.3^^107^1204^4
 ;;^UTILITY(U,$J,358.3,24445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24445,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,24445,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,24445,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,24446,0)
 ;;=E29.1^^107^1204^35
